Price Prediction: CoreWeave Has 124% Upside Despite Capex Concerns

Photo of Vandita Jadeja
By Vandita Jadeja Published

Quick Read

  • CRWV shares trade near $73 despite 112% revenue growth and a $99 billion backlog, giving our $163 price target roughly 124% upside.

  • Nebius (NBIS) and IREN target far less 2026 revenue than CRWV's $12 billion, making CoreWeave's 6x price-to-sales ratio look reasonable by comparison.

  • Even CRWV's bear-case target of $132 beats today's price, but $50 billion in liabilities and a fraud lawsuit create real downside risk.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and CoreWeave, Inc. Class A Common Stock didn't make the cut. Grab the names FREE today.

Price Prediction: CoreWeave Has 124% Upside Despite Capex Concerns

© metamorworks / iStock via Getty Images

CoreWeave (NASDAQ:CRWV) has become the poster child for the AI infrastructure gold rush, and also its most polarizing bet. Capital expenditures are set to run $31 billion to $35 billion in 2026 alone, dwarfing revenue and lighting up both the bull and bear thesis. Our model sees meaningful upside from here.

Our 24/7 Wall St. price target on CRWV is $163.32 over the next 12 months, versus a current price of $73.06. That implies 123.54% upside and a buy recommendation. Confidence is moderate at 50%, reflecting the tension between a nearly $100 billion backlog and a balance sheet stretched by breakneck capex.

An infographic with a dark background displays a 12-month price prediction for CoreWeave (CRWV). The current price is $73.06, with a target price of $163.32, indicating a +123.54% upside and a 'BUY' recommendation with a moderate 50% confidence level. A section 'HOW WE GOT THERE' shows a Weighted Base Price of $140.55 based on Analyst Consensus. 'OUR ADJUSTMENTS' illustrates the base price of $140.55 adjusted by positive factors like Sector Momentum (+$21.08) and Analyst Consensus (+$5.06), and negative factors such as Social Sentiment (-$1.26) and Large Cap Dampening (-$2.11), leading to a Final Target of $163.32. 'BULL CASE: What Could Go Right' lists items like 'Backlog Approaches $100B' and 'New Q1 Bookings >$40B', targeting $166.97 (+128.54% Upside). 'BEAR CASE: What Could Go Wrong' lists concerns such as '2026 Capex up to $35B' and 'Total Liabilities >$50B', with a target of $131.55 (+80.06% Upside). The bottom line reiterates a 'BUY' recommendation at $163.32 (+123.54% UPSIDE), stating CoreWeave's backlog and power pipeline justify the recommendation despite high capex risks and debt.
24/7 Wall St.

24/7 Wall St. Price Target Summary

Metric Value
Current Price $73.06
24/7 Wall St. Price Target $163.32
Upside 123.54%
Recommendation BUY
Confidence Level 50%

A Brutal Month for a Booming Business

CRWV has traded like a stock in crisis. Shares fell 38.06% over the past month and 40.61% over the past year, even as the business booked its strongest quarter yet.

Q1 2026 revenue hit $2.08 billion, up 111.7% year over year, while backlog reached $99.4 billion. A July Meta Compute announcement spooked investors about cannibalization. Debt has climbed to roughly $35 billion, net loss widened to $740 million, and interest expense doubled to $536 million.

The Case for $200 and Higher

Bulls have real ammunition. New Q1 bookings exceeded $40 billion, and management guides to $12 billion to $13 billion in 2026 revenue with low-double-digit adjusted operating margin by Q4. CoreWeave surpassed 1 GW of active power and targets more than 8 GW by 2030.

Investment-grade financing on DDTL 4.0 at sub-6% implied cost is a structural win. Rosenblatt’s John McPeake carries the most aggressive Street call at $250, reiterated after the Meta scare. Our bull-case scenario points to $166.97, roughly 128.54% upside.

What Could Go Wrong

The bear case starts with capex arithmetic. Q1 2026 free cash flow ran negative $4.71 billion, and 2026 capex guidance of up to $35 billion means CoreWeave will keep leaning on capital markets. Total liabilities sit above $50 billion.

A securities fraud class action alleging concealed data center delays adds legal overhang. Customer concentration is real: Meta and OpenAI alone represent tens of billions in commitments.

Management pushed back that gross margin compression to 68% is “predominantly timing-based, not economic” as new deployments ramp. Our bear-case target lands at $131.55, well above today’s price.

How CoreWeave Compares to Nebius and IREN

Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) competes for the same hyperscaler and AI-lab dollars. It achieved positive adjusted EBITDA of $129.5 million and carries a market cap of roughly $40 billion, similar to CRWV’s $39.9 billion. Yet Nebius’s 2026 revenue guide of $3 billion to $3.4 billion is a fraction of CoreWeave’s $12 billion to $13 billion. On a price-to-sales basis, CRWV at 6.41x trailing looks reasonable.

IREN (NASDAQ:IREN) is the smaller, faster-mover comparable. IREN targets $3.7 billion in ARR by end of 2026 with 5 gigawatts of secured power globally and a $3.4 billion NVIDIA cloud contract. At a market cap of roughly $14 billion, IREN trades cheaper on power secured, but CoreWeave has the contracted revenue lead. The peer set makes our $163.32 target reasonable, not aggressive.

CoreWeave Price Prediction 2026-2030

The setup on CRWV looks constructive. The 24/7 Wall St. price target of $163.32 reflects a company whose backlog and power pipeline justify a re-rate once operating margin inflects in the second half of 2026.

Confidence is moderate at 50% because debt and litigation are genuine tail risks. Watch for adjusted operating margin exiting Q4 in the low double digits as guided. The setup weakens if capex creeps above $35 billion without matching backlog conversion.

Year 24/7 Wall St. Price Target
2026 $101
2027 $163
2028 $260
2029 $420
2030 $560

These projections assume CoreWeave converts backlog on schedule and reaches its 8 GW power target by 2030. Meaningful upside or downside could come from Nvidia GPU pricing, litigation outcomes, or hyperscaler in-sourcing shifts.

Contact [email protected] for any questions or corrections.

Photo of Vandita Jadeja
About the Author Vandita Jadeja →

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

Continue Reading

Top Gaining Stocks

WDC Vol: 4,169,358
MU Vol: 27,172,989
TER Vol: 1,568,629
COIN Vol: 7,518,978
STX Vol: 2,969,292

Top Losing Stocks

DHR Vol: 15,078,006
CTRA Vol: 73,319,495
MSCI Vol: 1,117,401
EFX Vol: 3,684,134
HAL Vol: 16,660,845